adenosine A2A receptor antagonist

Indications

• adjunctive treatment of Parkinson's disease (investigational)

Mechanism of action

• inhibits adenosine A2A receptors

More general terms

• receptor antagonist

More specific terms

• istradefylline (Nourianz)
• preladenant
• tozadenant

Additional terms

• adenosine A2A receptor (ADORA2A, ADORA2)